Udomsak Sangkum

2.0k total citations · 1 hit paper
16 papers, 1.5k citations indexed

About

Udomsak Sangkum is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Udomsak Sangkum has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Virology, 15 papers in Epidemiology and 14 papers in Infectious Diseases. Recurrent topics in Udomsak Sangkum's work include HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (14 papers) and HIV, Drug Use, Sexual Risk (13 papers). Udomsak Sangkum is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (14 papers) and HIV, Drug Use, Sexual Risk (13 papers). Udomsak Sangkum collaborates with scholars based in Thailand and United States. Udomsak Sangkum's co-authors include Suphak Vanichseni, Kachit Choopanya, Pravan Suntharasamai, Michael Martin, Philip A. Mock, Sithisat Chiamwongpaet, Somyot Kittimunkong, Janet M. McNicholl, Manoj Leethochawalit and Lynn Paxton and has published in prestigious journals such as The Lancet, PLoS ONE and American Journal of Public Health.

In The Last Decade

Udomsak Sangkum

16 papers receiving 1.4k citations

Hit Papers

Antiretroviral prophylaxis for HIV infection in injecting... 2013 2026 2017 2021 2013 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Udomsak Sangkum Thailand 12 1.3k 1.1k 490 412 244 16 1.5k
Ioannis Hodges-Mameletzis Switzerland 13 1.4k 1.0× 928 0.8× 515 1.1× 245 0.6× 437 1.8× 20 1.5k
Somyot Kittimunkong Thailand 8 1.2k 0.9× 1.0k 0.9× 478 1.0× 334 0.8× 224 0.9× 11 1.3k
Roman Gvetadze United States 14 1.6k 1.2× 1.3k 1.2× 624 1.3× 413 1.0× 337 1.4× 23 1.8k
Manoj Leethochawalit Thailand 8 1.2k 0.9× 1.0k 0.9× 478 1.0× 334 0.8× 224 0.9× 9 1.3k
Sithisat Chiamwongpaet Thailand 9 1.3k 1.0× 1.2k 1.1× 503 1.0× 353 0.9× 239 1.0× 11 1.5k
Perry Kendall Canada 14 981 0.7× 937 0.8× 200 0.4× 444 1.1× 206 0.8× 31 1.4k
Víctoria Hernando Spain 19 1.1k 0.8× 804 0.7× 278 0.6× 379 0.9× 342 1.4× 55 1.5k
Michelle Rodolph Switzerland 11 1.1k 0.8× 861 0.8× 468 1.0× 171 0.4× 352 1.4× 19 1.2k
Shannon Hader United States 19 949 0.7× 670 0.6× 181 0.4× 260 0.6× 334 1.4× 33 1.1k
Eve Mokotoff United States 16 908 0.7× 717 0.6× 206 0.4× 256 0.6× 372 1.5× 28 1.2k

Countries citing papers authored by Udomsak Sangkum

Since Specialization
Citations

This map shows the geographic impact of Udomsak Sangkum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udomsak Sangkum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udomsak Sangkum more than expected).

Fields of papers citing papers by Udomsak Sangkum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Udomsak Sangkum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udomsak Sangkum. The network helps show where Udomsak Sangkum may publish in the future.

Co-authorship network of co-authors of Udomsak Sangkum

This figure shows the co-authorship network connecting the top 25 collaborators of Udomsak Sangkum. A scholar is included among the top collaborators of Udomsak Sangkum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Udomsak Sangkum. Udomsak Sangkum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Martin, Michael, Suphak Vanichseni, Udomsak Sangkum, et al.. (2019). HIV Incidence and Risk Behaviours of People Who Inject Drugs in Bangkok, 1995–2012. EClinicalMedicine. 9. 44–51. 11 indexed citations
2.
Martin, Michael, Suphak Vanichseni, Wanna Leelawiwat, et al.. (2019). Hepatitis C virus infection among people who inject drugs in Bangkok, Thailand, 2005–2010. WHO South-East Asia Journal of Public Health. 8(1). 50–50. 7 indexed citations
3.
Martin, Michael, Suphak Vanichseni, Pravan Suntharasamai, et al.. (2016). Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study. The Lancet HIV. 4(2). e59–e66. 40 indexed citations
4.
Martin, Michael, Suphak Vanichseni, Pravan Suntharasamai, et al.. (2015). The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs. AIDS. 29(7). 819–824. 79 indexed citations
5.
Suntharasamai, Pravan, Michael Martin, Kachit Choopanya, et al.. (2015). Assessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis Trial in Bangkok, Thailand. PLoS ONE. 10(12). e0145859–e0145859. 16 indexed citations
6.
Vanichseni, Suphak, Michael Martin, Pravan Suntharasamai, et al.. (2015). High Mortality Among Non–HIV-Infected People Who Inject Drugs in Bangkok, Thailand, 2005–2012. American Journal of Public Health. 105(6). 1136–1141. 5 indexed citations
7.
Martin, Michael, Suphak Vanichseni, Pravan Suntharasamai, et al.. (2014). Risk Behaviors and Risk Factors for HIV Infection among Participants in the Bangkok Tenofovir Study, an HIV Pre-Exposure Prophylaxis Trial among People Who Inject Drugs. PLoS ONE. 9(3). e92809–e92809. 21 indexed citations
8.
Choopanya, Kachit, Michael Martin, Pravan Suntharasamai, et al.. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. 381(9883). 2083–2090. 1086 indexed citations breakdown →
9.
Martin, Michael, Suphak Vanichseni, Pravan Suntharasamai, et al.. (2011). Enrollment Characteristics and Risk Behaviors of Injection Drug Users Participating in the Bangkok Tenofovir Study, Thailand. PLoS ONE. 6(9). e25127–e25127. 35 indexed citations
10.
Martin, Michael, Suphak Vanichseni, Pravan Suntharasamai, et al.. (2010). Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999–2003. International Journal of Drug Policy. 21(4). 296–301. 30 indexed citations
11.
Kittikraisak, Wanitchaya, Frits van Griensven, Michael Martin, et al.. (2009). Blood and Seminal Plasma HIV-1 RNA Levels Among HIV-1-Infected Injecting Drug Users Participating in the AIDSVAX B/E Efficacy Trial in Bangkok, Thailand. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(5). 601–608. 5 indexed citations
12.
13.
Pitisuttithum, Punnee, Kachit Choopanya, Valai Bussaratid, et al.. (2007). Social harms in injecting drug users participating in the first phase III HIV vaccine trial in Thailand.. PubMed. 90(11). 2442–8. 12 indexed citations
14.
Griensven, Frits van, Punnee Pitisuttithum, Suphak Vanichseni, et al.. (2005). Trends in the injection of midazolam and other drugs and needle sharing among injection drug users enrolled in the AIDSVAX B/E HIV-1 vaccine trial in Bangkok, Thailand. International Journal of Drug Policy. 16(3). 171–175. 21 indexed citations
15.
Nguyen, Lily H. P., Ming Li, Thanyanan Chaowanachan, et al.. (2004). CCR5 promoter human haplogroups associated with HIV-1 disease progression in Thai injection drug users. AIDS. 18(9). 1327–1333. 22 indexed citations
16.
Griensven, Frits van, Jordan W. Tappero, Udomsak Sangkum, et al.. (2004). Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand. AIDS. 18(2). 295–301. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026